Related Experiment Video
Updated: Jul 11, 2026
07:44
Surgical Injury to the Mouse Pancreas through Ligation of the Pancreatic Duct as a Model for Endocrine and Exocrine Reprogramming and Proliferation
Published on: August 7, 2015
Hyperplastic islets observed in "reversed" NOD mice treated without hematopoietic cells
Yoshiaki Okubo1, Akira Shimada, Yasuhiko Kanazawa
1Department of Internal Medicine, Keio University School of Medicine, 35 Shinanomachi Shinjuku-ku, Tokyo 160-8582, Japan.
Diabetes Research and Clinical Practice
|October 9, 2007
Summary
A novel therapy combining complete Freund's adjuvant (CFA) and MIN6N-9a pancreatic beta cells induced remission in recent-onset type 1 diabetes in mice. This approach shows promise for reversing autoimmune diabetes by enhancing beta cell function.
Area of Science:
- Immunology
- Endocrinology
- Regenerative Medicine
Background:
- Type 1 diabetes involves autoimmune destruction of pancreatic beta cells, leading to hyperglycemia.
- Reversing autoimmune diabetes requires depleting effector cells and promoting beta cell regeneration.
Purpose of the Study:
- To investigate a novel combination therapy for reversing autoimmune diabetes in a murine model.
- To evaluate the efficacy of complete Freund's adjuvant (CFA) and MIN6N-9a pancreatic beta cells in achieving diabetic remission.
Main Methods:
- NOD mice with recent-onset diabetes were treated with MIN6N-9a cells and CFA.
- Control groups received vehicle instead of MIN6N-9a cells.
- Pancreatic histology was examined to assess islet morphology and hyperplasia.
Main Results:
- 71% of mice treated with MIN6N-9a and CFA achieved normoglycemia within 120 days.
- Only 22% of control mice achieved remission.
- Histological analysis revealed marked hyperplasia of remaining islets in treated mice.
Conclusions:
- Combination therapy with CFA and MIN6N-9a cells can induce remission in autoimmune diabetes.
- Beta cell regeneration and hyperplasia play a key role in this reversal.
- Hematopoietic cell differentiation is not essential for reversing autoimmune diabetes in this model.
